BAHIA SOFTWARE is a technology company founded in 1999 and specialized in the health sector. The catalogue of services and products offered by BAHIA SOFTWARE covers the whole life cycle of software development from consulting services in specific technologies to the development of corporate information systems and including highly experienced teams in Interoperability and systems integration or data analytics.

BAHIA SOFTWARE activities demand a high knowledge of interoperability, the adoption of international standards and a deep understanding of health systems and eHealth technologies. To fulfil future demands of health systems. The company has an Innovation department carrying out R&D projects related with advanced techniques and technologies, such as the digitalization of samples from biobanks, the integration of Genomic data into Electronic Health record Systems, and platforms for telemedicine that integrate different silos of information.

Some of the challenges that BAHIA SOFTAWARE usually faces at hospitals (different standards, research and clinical data integration, storage capacity optimization, etc.) will be also faced in EUCAIM. As part of the EUCAIM consortium, BAHIA SOFTWARE will share its knowledge and experience about the use of opensource solutions for the management of complex data, such as imaging, structured clinical data, genomics, transcriptomics, etc.

Some of the challenges everyday raised by clinicians are also among the top priorities of EUCAIM like the following:

1) the creation of a platform integrating information from different sources (images, clinical data and metadata)

2) The promotion of international standards regarding interoperability and connectivity

3) The optimization of data storage

4) high robustness and maximum levels of cybersecurity

5) the combination of data obtained from different sources

6) the definition of corporate software solutions that can grow in line with the internal evolution of the organization, facilitating the incorporation of new functionalities and algorithms.

BAHIA SOFTWRE will significantly contribute to all these demands maximizing the knowledge and experience gained along the years and developing new tools based on R&D activities in close collaboration with EUCAIM researchers.

Role of institution in the project

BAHIA SOFTWARE will provide its experience in interoperability and the management of complex data, and is mainly involved in the following WPs:

WP2: Technical members of the engagement team. Assistance to data providers.

WP4: Integration of access to processing solutions and execution environments of WP6 to increase the quality and level of information of the data.

WP5: Definition of the Common Data Model, development of data toolsets. Support on the definition of procedures to join EUCAIM.

WP6: Analytical data exploitation tool, allowing the sharing of common protocols for the study of specific features of the data.

Sergio Figueiras

Sergio Figueiras, PhD in Chemistry and MBA is the director of innovation at Bahía Software. Sergio has more than 10 years of experience directing different initiatives at an international level and with financing from European funds. Before he joined Bahía Software, he was director of invasion of ACIS, the public innovation agency of the Galician health service where he coordinated different innovation and technology transfer projects and directed the development of different health technologies through innovative public procurement programs. He was appointed expert member of the Horizon 2020 committee on health, demographic change and well-being between 2017 and 2018.

Juan Prieto-Pena

Juan Prieto-Pena is an Innovation Project Manager at BAHIA SOFTWARE. Juan holds a PhD in Medical Physics, where he was tasked with the analysis of data coming from radiation detectors to assess the clinical dose prescribed to cancer patients. His work consists on the management of the activities of BAHIA SOFTWARE in different regional, national and international projects related to R&D+I and eHealth, such as CHAIMELEON (EC, 952172), COPERIA (GAIN, IN852D 2021/20) and participating in PCP projects such as ROSIA (EC, 101017606). His main role in EUCAIM is the management and support of the development teams in administrative tasks.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

March 14, 10:00-11:30 aM CET



Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.